This concept has recently been validated in a groundbreaking Nature study from Harvard (2025), which showed that reducing dietary lithium by ~50% in AD mouse models accelerated amyloid-β and tau pathology, increased microglial activation, and led to cognitive decline, whereas lithium orotate supplementation prevented these changes and preserved neuronal function (Aron et al., 2025). Here, MAPT is linked to Alzheimer disease.